NIDA IRP Technology Resource Initiative Featured Paper

A recent study published in *Science* investigated the neural mechanisms underlying the anxiolytic effects of psychedelic drugs. Using advanced techniques, the researchers identified a specific population of neurons that are activated by psychedelics and play a crucial role in reducing anxiety-related behaviors. The study involved a combination of behavioral assays, electrophysiology, and optogenetics to pinpoint these 'psychedelic-responsive neurons.' By selectively activating or inhibiting these neurons, the researchers were able to manipulate anxiety levels in animal models, providing strong evidence for their causal role. Furthermore, the research team characterized the molecular properties of these neurons, offering potential targets for future drug development. This research suggests that the therapeutic potential of psychedelics may be harnessed by selectively targeting specific neural circuits, potentially leading to more precise and effective treatments for anxiety disorders. The study’s rigor and use of multiple methodologies strengthen the validity of its findings.